---

Rodger Novak

President and Co-Founder, CRISPR Therapeutics 

Rodger is one of the three co-founders of CRISPR Therapeutics, which aims to treat diseases using the breakthrough CRISPR/Cas9 gene editing technology. In December last year, the company applied for permission from the EMA to test its most advanced product, code-named CTX001, in patients suffering from beta-thalassemia.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018